Strive Financial Group LLC Purchases 1,631 Shares of Lam Research Corporation $LRCX

Strive Financial Group LLC boosted its position in shares of Lam Research Corporation (NASDAQ:LRCXFree Report) by 110.1% during the 2nd quarter, HoldingsChannel.com reports. The fund owned 3,113 shares of the semiconductor company’s stock after buying an additional 1,631 shares during the quarter. Lam Research accounts for 0.6% of Strive Financial Group LLC’s investment portfolio, making the stock its 29th biggest holding. Strive Financial Group LLC’s holdings in Lam Research were worth $1,349,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Paladin Partners LLC bought a new stake in shares of Lam Research in the 2nd quarter valued at about $26,000. Bravera Wealth bought a new position in Lam Research during the second quarter worth about $46,000. Cedar Mountain Advisors LLC increased its position in Lam Research by 242.9% during the first quarter. Cedar Mountain Advisors LLC now owns 120 shares of the semiconductor company’s stock worth $26,000 after buying an additional 85 shares during the last quarter. Comprehensive Financial Planning Inc. PA acquired a new position in Lam Research during the second quarter worth approximately $52,000. Finally, Vermillion Wealth Management Inc. bought a new stake in Lam Research in the first quarter valued at approximately $26,000. Institutional investors own 84.61% of the company’s stock.

Lam Research Price Performance

Shares of Lam Research stock opened at $307.65 on Friday. The company has a quick ratio of 1.91, a current ratio of 2.63 and a debt-to-equity ratio of 0.30. The stock has a market capitalization of $384.97 billion, a price-to-earnings ratio of 53.41, a price-to-earnings-growth ratio of 1.16 and a beta of 1.85. Lam Research Corporation has a twelve month low of $100.68 and a twelve month high of $438.50. The company has a 50-day simple moving average of $321.34 and a two-hundred day simple moving average of $291.39.

Lam Research (NASDAQ:LRCXGet Free Report) last announced its earnings results on Wednesday, July 29th. The semiconductor company reported $1.82 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.69 by $0.13. Lam Research had a net margin of 31.27% and a return on equity of 67.60%. The firm had revenue of $6.72 billion for the quarter, compared to analyst estimates of $6.66 billion. During the same quarter in the prior year, the business posted $1.33 EPS. The business’s revenue was up 30.0% compared to the same quarter last year. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. Analysts forecast that Lam Research Corporation will post 9.33 EPS for the current year.

Lam Research Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 14th. Investors of record on Wednesday, September 23rd will be given a dividend of $0.33 per share. This is an increase from Lam Research’s previous quarterly dividend of $0.26. This represents a $1.32 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date of this dividend is Wednesday, September 23rd. Lam Research’s dividend payout ratio (DPR) is currently 18.06%.

Insider Buying and Selling

In other news, Director Abhijit Y. Talwalkar sold 18,282 shares of the company’s stock in a transaction on Monday, July 13th. The stock was sold at an average price of $335.00, for a total transaction of $6,124,470.00. Following the completion of the sale, the director directly owned 87,142 shares in the company, valued at approximately $29,192,570. This represents a 17.34% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Ava Harter sold 5,000 shares of the stock in a transaction on Monday, August 31st. The stock was sold at an average price of $302.46, for a total value of $1,512,300.00. Following the sale, the insider directly owned 42,462 shares in the company, valued at approximately $12,843,056.52. This trade represents a 10.53% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 77,782 shares of company stock valued at $26,755,370 over the last 90 days. 0.31% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several brokerages have recently commented on LRCX. TD Cowen reiterated a “buy” rating and set a $400.00 target price (up from $340.00) on shares of Lam Research in a research note on Thursday, July 9th. Jefferies Financial Group set a $335.00 price target on Lam Research and gave the company a “buy” rating in a report on Thursday, July 30th. Cantor Fitzgerald set a $500.00 price objective on shares of Lam Research and gave the stock an “overweight” rating in a research report on Monday, June 29th. Zacks Research upgraded shares of Lam Research from a “hold” rating to a “strong-buy” rating in a report on Friday, July 17th. Finally, Wells Fargo & Company reissued an “overweight” rating and issued a $350.00 price objective (down from $450.00) on shares of Lam Research in a research report on Thursday, July 30th. One analyst has rated the stock with a Strong Buy rating, twenty-six have given a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat.com, Lam Research presently has a consensus rating of “Moderate Buy” and a consensus target price of $358.97.

Read Our Latest Research Report on Lam Research

Key Stories Impacting Lam Research

Here are the key news stories impacting Lam Research this week:

  • Positive Sentiment: Lam Research’s record June-quarter results and outlook remain key catalysts. Revenue reached $6.72 billion, up 30% year over year, while adjusted earnings exceeded analysts’ expectations. Management guided for approximately $8.10 billion in September-quarter revenue, reinforcing confidence in continued AI- and advanced-chip-related demand. Lam Research gains as investors build on strong guidance and recent shareholder-friendly updates
  • Positive Sentiment: The company broke ground on a new Oregon research laboratory and plans to invest more than $3 billion in its global lab network over five years. The investment is intended to support semiconductor research tied to artificial intelligence and next-generation chip production. Lam Research Oregon laboratory announcement
  • Positive Sentiment: Lam Research raised its quarterly dividend by approximately 27% to $0.33 per share, improving the stock’s shareholder-return profile after its record quarter. Lam Research dividend increase
  • Positive Sentiment: Options activity and bullish institutional positioning may be adding to momentum. More than 1,600 institutions reportedly increased their holdings in the latest quarter, while recent analyst targets—including several between $400 and $500—remain above the current trading range. Lam Research options market article
  • Neutral Sentiment: The dividend increase has attracted attention as investors seek income and quality amid geopolitical and inflation concerns, although broader market volatility could continue to affect semiconductor stocks. Stocks with dividend hikes article
  • Negative Sentiment: Insiders have reported only sales—not purchases—in the past six months, including transactions by CEO Timothy Archer and other executives. That activity may raise concerns about valuation or profit-taking.
  • Negative Sentiment: After substantial long-term gains, some commentary argues that LRCX is fully valued, with elevated valuation metrics leaving less room for disappointment-free execution. UBS also recently lowered its price target to $425, despite remaining above the current share price. UBS lowers Lam Research price target

Lam Research Company Profile

(Free Report)

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.

Featured Stories

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCXFree Report).

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.